CN1785977A - 17-sulfonyl diversine and its preparation method - Google Patents
17-sulfonyl diversine and its preparation method Download PDFInfo
- Publication number
- CN1785977A CN1785977A CN200510123090.4A CN200510123090A CN1785977A CN 1785977 A CN1785977 A CN 1785977A CN 200510123090 A CN200510123090 A CN 200510123090A CN 1785977 A CN1785977 A CN 1785977A
- Authority
- CN
- China
- Prior art keywords
- sinomenine
- benzyloxybenzyl
- preparation
- sulfonyl
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一类17-磺酰基青藤碱,它具有潜在的药物应用前景,其结构式如图,结构式中R=R1S(OO)-,R1=甲基、乙基、丙基、三氟甲基的烃基及取代烃基;R1=苯基及取代苯基。在青藤碱17位化合物的合成过程中,采用苄氧苄基保护酚羟基的方法,脱保护时用烯三氟乙酸在室温进行,条件温和,反应速度快,该合成过程具有副反应少、收率高的优点,平均收率在90%左右,并且与苄基保护方法相比不产生双键氢化等现象。
The invention discloses a class of 17-sulfonylsinomenine, which has potential drug application prospects. Its structural formula is as shown in the figure. In the structural formula, R=R 1 S(OO)-, R 1 =methyl, ethyl, propyl , hydrocarbon groups and substituted hydrocarbon groups of trifluoromethyl; R 1 =phenyl and substituted phenyl groups. In the synthesis process of the 17-position compound of sinomenine, the method of protecting the phenolic hydroxyl group with benzyloxybenzyl group is used, and the deprotection is carried out at room temperature with trifluoroacetic acid. The conditions are mild and the reaction speed is fast. The synthesis process has less side reactions, The advantage of high yield, the average yield is about 90%, and compared with the benzyl protection method does not produce double bond hydrogenation and other phenomena.
Description
一、技术领域1. Technical field
本发明涉及一类有机化合物及其制法,具体地说是涉及一类17-磺酰基青藤碱及其制备方法。The present invention relates to a class of organic compounds and a preparation method thereof, in particular to a class of 17-sulfonyl sinomenine and a preparation method thereof.
二、背景技术2. Background technology
青藤碱(sinomenine)是从防风己科植物青风藤及毛青藤的根茎中提取的吗啡(morphine)类生物碱。据有关文献记载(CN98120549,1142946,1149456,US9903753),具有抗炎、镇痛、降压、抗心律失常等药理活性,临床主要用于治疗类风湿性关节炎、脑缺血、神经功能失调等症状。Sinomenine (sinomenine) is a morphine alkaloid extracted from the rhizomes of S. chinensis and S. tomentosa. According to relevant literature records (CN98120549, 1142946, 1149456, US9903753), it has pharmacological activities such as anti-inflammatory, analgesic, antihypertensive, antiarrhythmic, etc. It is mainly used clinically to treat rheumatoid arthritis, cerebral ischemia, neurological dysfunction, etc. symptom.
最近的研究(WO2004048340)发现青藤碱及其衍生物(采用小鼠Morris watermaze test,Social recognition test,NaNO2 induced anoxia test)还具有益智、抗毒、保护神经的功效。A recent study (WO2004048340) found that sinomenine and its derivatives (using mouse Morris watermaze test, Social recognition test, NaNO 2 induced anoxia test) also have the effects of nootropic, anti-drug, and neuroprotective.
在专利CN.1153171中,报道了青络锗-金属锗的青藤碱配合物作为广谱抗癌药物,具有毒副作用小、不降低人体免疫功能、有效抑瘤的优点。CN.02137445.7报道了青藤碱磷脂复合物用于治疗风湿性关节炎、心律失常。该专利指出复合物具有较母体药物更强的亲脂性,其抗炎活性显著提高。In the patent CN.1153171, it is reported that the sinomenine complex of cyanogermanium-metal germanium is used as a broad-spectrum anticancer drug, which has the advantages of less toxic and side effects, no reduction in human immune function, and effective tumor suppression. CN.02137445.7 reports that sinomenine phospholipid complex is used for treating rheumatoid arthritis and arrhythmia. The patent pointed out that the complex has stronger lipophilicity than the parent drug, and its anti-inflammatory activity is significantly improved.
对N-去甲基青藤碱的研究表明N-去甲基青藤碱与青藤碱相比具有更高的生理活性并指出其活性与亲水性有一定的关系,其盐、酚酯衍生物具有治疗功能失调、风湿性关节炎等作用。(US9903753、US6372756)。The research on N-desmethyl sinomenine shows that N-desmethyl sinomenine has higher physiological activity compared with sinomenine and points out that its activity has a certain relationship with hydrophilicity. Its salt, phenolic ester Derivatives have the functions of treating dysfunction, rheumatoid arthritis and the like. (US9903753, US6372756).
叶仙蓉等(药学学报,2004,39(3),180-183)对含羰基环进行了修饰得到了系列化合物,与青藤碱相比,采用巴豆油致小鼠耳胀法发现与羰基共轭的双键被饱和时(7-甲氧基-二氢青藤碱)的活性保持,而对小鼠醋酸扭体法试验中该化合物的镇痛活性优于青藤碱。Ye Xianrong et al. (Acta Pharmacologica Sinica, 2004, 39(3), 180-183) modified the carbonyl-containing ring to obtain a series of compounds. Compared with sinomenine, it was found that it was conjugated with carbonyl by croton oil-induced mouse ear swelling method. The activity of (7-methoxyl-dihydrosinomenine) is maintained when the double bond is saturated, and the analgesic activity of this compound is better than that of sinomenine in the acetic acid writhing test of mice.
三、发明内容3. Contents of the invention
本发明的目的在于提供一类17-磺酰基青藤碱;及其采用苄氧苄基保护酚羟基方法,脱保护时用稀三氟乙酸/二氯甲烷液室温进行,条件温和,反应速度快,并提供制备17-磺酰基青藤碱的方法。The object of the present invention is to provide a class of 17-sulfonyl sinomenine; and the method of protecting the phenolic hydroxyl group by benzyloxybenzyl, and carry out at room temperature with dilute trifluoroacetic acid/dichloromethane liquid during deprotection, with mild conditions and fast reaction speed , and provide a method for preparing 17-sulfonyl sinomenine.
本发明的目的是通过以下的技术方案来实现的:The purpose of the present invention is achieved by the following technical solutions:
一类17-磺酰基青藤碱,其结构式如下:A class of 17-sulfonyl sinomenine, its structural formula is as follows:
其中R=R1S(O0)-,R1=甲基、乙基、丙基、三氟甲基等烃基及取代烃基;或R1=苯基及取代苯基。Wherein R=R 1 S(O0)-, R 1 = methyl, ethyl, propyl, trifluoromethyl and other hydrocarbon groups and substituted hydrocarbon groups; or R 1 = phenyl and substituted phenyl groups.
本发明涉及的一类17-磺酰基青藤碱的制备方法的反应过程如下:The reaction process of the preparation method of a class of 17-sulfonyl sinomenine that the present invention relates to is as follows:
一类17-磺酰基青藤碱的制备方法,其制备步骤如下:A kind of preparation method of 17-sulfonyl sinomenine, its preparation steps are as follows:
(1)、4-苄氧苄基青藤碱(IV)的制备:取青藤碱(III)、三苯基膦、4-苄氧苄醇以足够量的溶剂溶解,0-20℃下滴加偶氮二甲酸二乙酯,0.5-2hr内加完,继续搅拌至反应结束得到4-苄氧苄基青藤碱,收率80.0-99.0%;其中三苯基膦、苄醇、偶氮二甲酸二乙酯的用量同为青腾碱(III)用量的1.5-5.0倍(mol),所述溶剂是四氢呋喃、甲苯或两者混合物;(1), the preparation of 4-benzyloxybenzylsinomenine (IV): take sinomenine (III), triphenylphosphine, and 4-benzyloxybenzyl alcohol and dissolve them in a sufficient amount of solvent, and dissolve them at 0-20°C Add diethyl azodicarboxylate dropwise, finish adding within 0.5-2hr, continue to stir until the end of the reaction to obtain 4-benzyloxybenzyl sinomenine with a yield of 80.0-99.0%; wherein triphenylphosphine, benzyl alcohol, The consumption of diethyl azodicarboxylate is 1.5-5.0 times (mol) the same as that of cyantium (III), and the solvent is tetrahydrofuran, toluene or a mixture of the two;
(2)、17-去甲基-4-苄氧苄基青藤碱(V)的制备:将4-苄氧苄基青藤碱用溶(2), the preparation of 17-demethyl-4-benzyloxybenzyl sinomenine (V): the 4-benzyloxybenzyl sinomenine is dissolved in
剂溶解,然后在缚酸剂存在下与氯甲酸-1-氯乙酯反应,得到N-(1-氯乙氧甲酰基)-4-苄氧苄基青藤碱;其中所用溶剂是1,2-二氯乙烷、氯仿、二氯甲烷、丙酮、甲苯等非质子溶剂;所述缚酸剂为碱金属碳酸盐,如碳酸氢钠、碳酸钠、碳酸钾等,其用量为4-苄氧苄基青藤碱的1.0-6.0倍(质量);氯甲酸-1-氯乙酯用量为苄氧苄基青藤碱0.1-3.0倍(质量);Dissolving agent, then react with chloroformic acid-1-chloroethyl ester in the presence of acid-binding agent to obtain N-(1-chloroethoxyformyl)-4-benzyloxybenzyl sinomenine; wherein the solvent used is 1, Aprotic solvents such as 2-dichloroethane, chloroform, dichloromethane, acetone, toluene; Described acid binding agent is alkali metal carbonate, as sodium bicarbonate, sodium carbonate, potassium carbonate etc., and its consumption is 4- 1.0-6.0 times (quality) of benzyloxybenzyl sinomenine; chloroformic acid-1-chloroethyl ester consumption is 0.1-3.0 times (quality) of benzyloxybenzyl sinomenine;
上步反应的剩余物直接加入到足够量的甲醇中,氮气保护下加热回流得到17-去甲基-4-苄氧苄基青藤碱(V)及其盐酸盐混合物,此混合物以氯仿分散,碳酸氢钠溶液中和得到17-去甲基-4-苄氧苄基青藤碱;The residue of the last step reaction is directly added in a sufficient amount of methanol, and heated under nitrogen to reflux to obtain 17-demethyl-4-benzyloxybenzyl sinomenine (V) and its hydrochloride mixture, and this mixture is dissolved in chloroform Disperse and neutralize with sodium bicarbonate solution to obtain 17-desmethyl-4-benzyloxybenzyl sinomenine;
(3)、17-磺酰基-4-苄氧苄基青藤碱(VI)的制备:取上述17-去甲基-4-苄氧苄基青藤碱(V),用溶剂融解后,在缚酸剂存在下与磺酰氯反应,得到17-磺酰基-4-苄氧苄基青藤碱(VI);缚酸剂是有机碱、如三乙胺、吡啶等,或是无机碱、如碳酸钠、碳酸氢钠等;(3), the preparation of 17-sulfonyl-4-benzyloxybenzyl sinomenine (VI): take the above-mentioned 17-demethyl-4-benzyloxybenzyl sinomenine (V), after melting with a solvent, React with sulfonyl chloride in the presence of an acid-binding agent to obtain 17-sulfonyl-4-benzyloxybenzyl sinomenine (VI); the acid-binding agent is an organic base, such as triethylamine, pyridine, etc., or an inorganic base, Such as sodium carbonate, sodium bicarbonate, etc.;
(4)、17-磺酰基青藤碱(I)的制备:取17-磺酰基-4-苄氧苄基青藤碱在室温下以2-20%三氟乙酸/二氯甲烷溶液处理得到17-磺酰基青藤碱。(4), the preparation of 17-sulfonyl sinomenine (I): get 17-sulfonyl-4-benzyloxybenzyl sinomenine at room temperature with 2-20% trifluoroacetic acid/dichloromethane solution to obtain 17-sulfonylsinomenine.
有益效果:Beneficial effect:
我们在青藤碱17位衍生物的合成过程中,参照文献(Bruce C.Hamper,Tetrahedron Letters,37(21),3671-3674.M.Mergler,Tetrahedron Letters,29(32),4005-8.)报道的方法,采用苄氧苄基保护酚羟基;脱除保护基是比较关键的一步,我们采用稀三氟乙酸/二氯甲烷溶液室温进行脱除保护,发现条件温和,反应速度快(2-10min),副反应少,收率高(收率均在90%以上),这种条件下脱除保护,不产生双键氢化现象。In the synthetic process of the 17-position derivative of sinomenine, we refer to literature (Bruce C.Hamper, Tetrahedron Letters, 37(21), 3671-3674.M.Mergler, Tetrahedron Letters, 29(32), 4005-8. ) method, using benzyloxybenzyl to protect the phenolic hydroxyl group; removing the protecting group is a more critical step, we use dilute trifluoroacetic acid/dichloromethane solution to remove the protection at room temperature, and found that the conditions are mild and the reaction speed is fast (2 -10min), less side reactions, high yield (yields are all above 90%), deprotection under this condition does not produce double bond hydrogenation phenomenon.
一类17-磺酰基青藤碱如结构式的部分化合物名称编号及其理化常数见下表:A class of 17-sulfonyl sinomenine such as part of the compound name number of the structural formula and its physical and chemical constants are shown in the following table:
四、具体实施方式4. Specific implementation
实施例1 17-丙磺酰基青藤碱(化合物3)的制备,其制备步骤如下:The preparation of embodiment 1 17-propanesulfonyl sinomenine (compound 3), its preparation steps are as follows:
(1)、4-苄氧苄基青藤碱(IV)的制备:参照(Yukiohitotsuyanagi,J.Org.Chem.,1995,60,4549-58.);(1) Preparation of 4-benzyloxybenzylsinomenine (IV): refer to (Yukiohitotsuyanagi, J.Org.Chem., 1995, 60, 4549-58.);
在100ml三口烧瓶中依次加入1.65g青藤碱,4.08g PPh3、2.97g苄氧苄醇和40.0ml绝对四氢呋喃,开动搅拌,冰浴冷却至0℃下滴加2.65gDEAD,30min内加完,取去冰浴,继续搅拌,以TLC检测反应进度,约10hr后反应结束,减压除去溶剂,以硅胶色谱柱装柱,依次用乙酸乙酯及6∶1的氯仿/甲醇淋洗,得到浅黄产品,乙醚重结晶得到2.6g白色固体4-苄氧苄基青藤碱(IV);mp 72℃;[α]25 D-69.0°(c=0.28 CH2Cl2);1HNMR(300MHz,DCCl3)δ7.56(d,2H,J=8.6Hz.),7.48-7.34(m,4H),7.02(d,2H,J=8.6Hz.),6.77(dd,2H,J=8.4Hz.),5.52(d,1H,J=1.5Hz.),5.23(d,1H,=10.5Hz.),5.11(s,2H),5.01(d,1H,J=10.5Hz),4.20(d,1H,J=16.1Hz.),3.83(s,3H),3.53(s,3H),3.18-3.16(m,1H),3.05-2.97(m,2H),2.82-2.73(m,1H),2.49-2.37(m,2H),2.43(s,3H),1.97(ddd,1H,J=4.3,11.4,11.4Hz.),1.87-1.80(m,2H);Add 1.65g of sinomenine, 4.08g of PPh 3 , 2.97g of benzyloxybenzyl alcohol and 40.0ml of absolute tetrahydrofuran into a 100ml three-necked flask in sequence, start stirring, and add 2.65g of DEAD dropwise under ice-cooling to 0°C. The addition is completed within 30min, and the Remove from the ice bath, continue to stir, and check the progress of the reaction with TLC. After about 10 hours, the reaction is complete. Remove the solvent under reduced pressure, pack it into a silica gel chromatography column, and wash it with ethyl acetate and 6:1 chloroform/methanol in sequence to obtain a light yellow product. , recrystallized from diethyl ether to obtain 2.6g white solid 4-benzyloxybenzyl sinomenine (IV); mp 72°C; [α] 25 D -69.0°(c=0.28 CH 2 Cl 2 ); 1 HNMR (300MHz, DCCl 3 ) δ7.56(d, 2H, J=8.6Hz.), 7.48-7.34(m, 4H), 7.02(d, 2H, J=8.6Hz.), 6.77(dd, 2H, J=8.4Hz. ), 5.52(d, 1H, J=1.5Hz.), 5.23(d, 1H,=10.5Hz.), 5.11(s, 2H), 5.01(d, 1H, J=10.5Hz), 4.20(d, 1H, J=16.1Hz.), 3.83(s, 3H), 3.53(s, 3H), 3.18-3.16(m, 1H), 3.05-2.97(m, 2H), 2.82-2.73(m, 1H), 2.49-2.37(m, 2H), 2.43(s, 3H), 1.97(ddd, 1H, J=4.3, 11.4, 11.4Hz.), 1.87-1.80(m, 2H);
(2)、17-去甲基-4-苄氧苄基青藤碱(V)的制备:参照(R.A.Olofson,J.Org.Chem.49(11),2081-2082);(2), preparation of 17-desmethyl-4-benzyloxybenzylsinomenine (V): refer to (R.A.Olofson, J.Org.Chem.49(11), 2081-2082);
1.0g 4-苄氧苄基青藤碱以10.0ml二氯乙烷溶解,加入碳酸氢钠1.0g,搅拌下冷却到0℃,滴加0.3g氯甲酸-1-氯乙酯,保温1-2hr,撤去冰水浴,升温至微回流0.5-1hr,冷却到室温,过滤,旋去溶剂,所得中间产物不经精制,直接加入到20ml的甲醇中,氮气保护下加热回流15min,减压除去溶剂,所得产品为17-去甲基-4-苄氧苄基青藤碱及其盐酸盐混合物,以氯仿分散,碳酸氢钠中和得到17-丙磺酰基-4-苄氧苄基青藤碱;Dissolve 1.0g of 4-benzyloxybenzylsinomenine in 10.0ml of dichloroethane, add 1.0g of sodium bicarbonate, cool to 0°C under stirring, add dropwise 0.3g of chloroformic acid-1-chloroethyl ester, and keep warm for 1- 2hr, remove the ice-water bath, raise the temperature to slight reflux for 0.5-1hr, cool to room temperature, filter, spin off the solvent, the obtained intermediate product is not refined, directly added to 20ml of methanol, heated to reflux for 15min under nitrogen protection, and the solvent is removed under reduced pressure , the resulting product is 17-desmethyl-4-benzyloxybenzyl sinomenine and its hydrochloride mixture, dispersed with chloroform, neutralized by sodium bicarbonate to obtain 17-propanesulfonyl-4-benzyloxybenzyl sinomenine alkali;
(3)、17-丙磺酰基-4-苄氧苄基青藤碱(VI,R=丙磺酰基)的制备;(3), preparation of 17-propanesulfonyl-4-benzyloxybenzyl sinomenine (VI, R=propanesulfonyl);
100mg 17-去甲基-4-苄氧苄基青藤碱,二氯甲烷10ml,0.1ml三乙胺,冰水浴下滴加50mg丙烷磺酰氯,TLC跟踪反应至完全,水洗,减压除去溶剂以硅胶色谱柱精制,得105mg 17-丙磺酰基-4-苄氧苄基青藤碱;[α]25 D+210.5°(c=0.06CH2Cl2)1HNMR(300MHz,DCCl3)7.56(d,1H,J=8.7Hz),7.48-7.34(m,4H),7.03(d,1H,J=8.7Hz),6.81(d,1H,J=8.7Hz),6.78(d,1H,J=8.7Hz),5.47(s,1H),5.27(d,1H,J=10.5Hz),5.11(s,1H),5.01(d,1H,J=10.5Hz),4.37(s,1H),4.21(d,1H,J=15.9Hz),3.85(s,3H),3.53(s,3H),3.52-3.44(m,1H),3.28-3.20(m,1H),2.97-2.85(m,4H),2.74-2.55(m,1H),2.47(d,1H,J=15.9Hz)1.94-1.83(m,3H),1.80-1.65(m,1H),1.07(t,3H,J=7.2Hz);100mg 17-desmethyl-4-benzyloxybenzylsinomenine, 10ml dichloromethane, 0.1ml triethylamine, 50mg propanesulfonyl chloride was added dropwise in an ice-water bath, followed by TLC until the reaction was complete, washed with water, and the solvent was removed under reduced pressure Purified by silica gel column to obtain 105mg 17-propanesulfonyl-4-benzyloxybenzyl sinomenine; [α] 25 D +210.5°(c=0.06CH 2 Cl 2 ) 1 HNMR (300MHz, DCCl 3 ) 7.56 (d, 1H, J=8.7Hz), 7.48-7.34(m, 4H), 7.03(d, 1H, J=8.7Hz), 6.81(d, 1H, J=8.7Hz), 6.78(d, 1H, J=8.7Hz), 5.47(s, 1H), 5.27(d, 1H, J=10.5Hz), 5.11(s, 1H), 5.01(d, 1H, J=10.5Hz), 4.37(s, 1H) , 4.21(d, 1H, J=15.9Hz), 3.85(s, 3H), 3.53(s, 3H), 3.52-3.44(m, 1H), 3.28-3.20(m, 1H), 2.97-2.85(m , 4H), 2.74-2.55(m, 1H), 2.47(d, 1H, J=15.9Hz), 1.94-1.83(m, 3H), 1.80-1.65(m, 1H), 1.07(t, 3H, J= 7.2Hz);
(4)、17-丙磺酰基青藤碱(化合物3)的制备:参照(Bruce C.Hamper,Tetrahedron Letters,37(21),3671-3674.M.Mergler,Tetrahedron Letters,29(32),4005-8.)的制备;(4), the preparation of 17-propanesulfonylsinomenine (compound 3): refer to (Bruce C.Hamper, Tetrahedron Letters, 37 (21), 3671-3674.M.Mergler, Tetrahedron Letters, 29 (32), 4005-8.) preparation;
50mg 17-丙磺酰基-4-苄氧苄基青藤碱以5ml 5%三氟乙酸/二氯甲烷溶液处理5min,加入10%碳酸氢钠溶液20ml中和,分出有机层,无水硫酸钠干燥,减压脱去溶剂以硅胶色谱柱精制,得化合物3;mp 110.0-113.0℃;[α]25 D+48.2°(c=0.35 CH2Cl2);1HNMR(300MHz,DCCl3)δH6.69(d,1H,J=8.4Hz.),6.57(d,1H,J=8.4Hz.),6.04(s,1H),5.44(d,1H,J=1.8Hz.),4.40-4.35(m,2H.),3.84(s,3H),3.56-3.54(m,1H),3.51(s,3H),3.18-3.16(m,1H),3.02-2.95(m,3H),2.91-2.85(m,1H),2.83-2.76(m,1H),2.48(d,1H,J=16.0Hz.),2.07-2.01(m,1H),1.90-1.82(m,3H),1.08(t,3H,J=7.4Hz.)。50mg of 17-propanesulfonyl-4-benzyloxybenzyl sinomenine was treated with 5ml of 5% trifluoroacetic acid/dichloromethane solution for 5min, and 20ml of 10% sodium bicarbonate solution was added to neutralize, the organic layer was separated, and anhydrous sulfuric acid Dry over sodium, remove the solvent under reduced pressure and purify by silica gel column chromatography to obtain compound 3; mp 110.0-113.0°C; [α] 25 D +48.2°(c=0.35 CH 2 Cl 2 ); 1 HNMR (300MHz, DCCl 3 ) δ H 6.69(d, 1H, J=8.4Hz.), 6.57(d, 1H, J=8.4Hz.), 6.04(s, 1H), 5.44(d, 1H, J=1.8Hz.), 4.40- 4.35(m, 2H.), 3.84(s, 3H), 3.56-3.54(m, 1H), 3.51(s, 3H), 3.18-3.16(m, 1H), 3.02-2.95(m, 3H), 2.91 -2.85(m, 1H), 2.83-2.76(m, 1H), 2.48(d, 1H, J=16.0Hz.), 2.07-2.01(m, 1H), 1.90-1.82(m, 3H), 1.08( t, 3H, J=7.4Hz.).
实施例2:17-对甲苯磺酰基青藤碱(化合物4)的制备,其制备步骤如下:Embodiment 2: the preparation of 17-p-toluenesulfonyl sinomenine (compound 4), its preparation steps are as follows:
(1)、17-(对甲基苯磺酰基)-4-苄氧苄基青藤碱的制备(1), the preparation of 17-(p-methylbenzenesulfonyl)-4-benzyloxybenzyl sinomenine
100mg 17-去甲基-4-苄氧苄基青藤碱,二氯甲烷10ml,0.1ml三乙胺,冰水浴下滴加50mg对甲基苯磺酰氯,TLC跟踪反应至完全,水洗,干燥减压蒸去溶剂,产品不经纯化直接用于下步反应;100mg 17-desmethyl-4-benzyloxybenzyl sinomenine, 10ml dichloromethane, 0.1ml triethylamine, 50mg p-toluenesulfonyl chloride was added dropwise in an ice-water bath, TLC tracked the reaction until complete, washed with water, and dried The solvent was evaporated under reduced pressure, and the product was directly used in the next step without purification;
(2)、17-对甲苯磺酰基青藤碱的制备(2), the preparation of 17-p-toluenesulfonyl sinomenine
100mg17-(对甲基苯磺酰基)-4-苄氧苄基青藤碱的粗品以5ml 5%三氟乙酸/二氯甲烷溶液室温处理5min,水洗、干燥,减压蒸去溶剂,产品以硅胶层析分离得到化合物4;mp 141.0-143.0℃;[α]25 D+92.4°(c=0.49 CH2Cl2);1HNMR(300MHz,DCCl3)δH7.74(d,2H,J=7.6Hz.),7.33(d,2H,J=7.6Hz.),6.62(d,1H,J=8.3Hz.),6.38(d,1H,J=8.3Hz.),6.00(s,1H),5.40(s,1H),4.49(s,1H),4.32(d,1H,J=15.70Hz.),3.80(s,3H),3.71-3.67(m,1H),3.49(s,3H),3.05-2.99(m,1H),2.84(s,1H),2.74-2.59(m,2H),2.46(s,3H),2.37(d,1H,J=15.7Hz.),1.97-1.93(m,1H),1.75-1.70(m,1H)。The crude product of 100mg 17-(p-toluenesulfonyl)-4-benzyloxybenzylsinomenine was treated with 5ml 5% trifluoroacetic acid/dichloromethane solution at room temperature for 5min, washed with water, dried, and the solvent was evaporated under reduced pressure. The product was Compound 4 was obtained by silica gel chromatography; mp 141.0-143.0°C; [α] 25 D +92.4° (c=0.49 CH 2 Cl 2 ); 1 HNMR (300MHz, DCCl 3 ) δ H 7.74 (d, 2H, J= 7.6Hz.), 7.33(d, 2H, J=7.6Hz.), 6.62(d, 1H, J=8.3Hz.), 6.38(d, 1H, J=8.3Hz.), 6.00(s, 1H) , 5.40(s, 1H), 4.49(s, 1H), 4.32(d, 1H, J=15.70Hz.), 3.80(s, 3H), 3.71-3.67(m, 1H), 3.49(s, 3H) , 3.05-2.99(m, 1H), 2.84(s, 1H), 2.74-2.59(m, 2H), 2.46(s, 3H), 2.37(d, 1H, J=15.7Hz.), 1.97-1.93( m, 1H), 1.75-1.70 (m, 1H).
Claims (5)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510123090.4A CN1785977A (en) | 2005-12-15 | 2005-12-15 | 17-sulfonyl diversine and its preparation method |
| JP2008545875A JP2009519960A (en) | 2005-12-15 | 2006-12-15 | Preparation and use of sinomenine derivatives |
| PCT/US2006/048086 WO2007070703A2 (en) | 2005-12-15 | 2006-12-15 | Sinomenine derivatives and preparation and uses thereof |
| US12/096,543 US7932264B2 (en) | 2005-12-15 | 2006-12-15 | Sinomenine derivatives and preparation and uses thereof |
| EP06847694A EP1959956A2 (en) | 2005-12-15 | 2006-12-15 | Sinomenine derivatives and preparation and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510123090.4A CN1785977A (en) | 2005-12-15 | 2005-12-15 | 17-sulfonyl diversine and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1785977A true CN1785977A (en) | 2006-06-14 |
Family
ID=36783595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200510123090.4A Pending CN1785977A (en) | 2005-12-15 | 2005-12-15 | 17-sulfonyl diversine and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1785977A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101148437B (en) * | 2007-11-05 | 2010-06-02 | 南京大学 | Bisinomenine derivatives linked by carbon-carbon mode, preparation method and application thereof |
-
2005
- 2005-12-15 CN CN200510123090.4A patent/CN1785977A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101148437B (en) * | 2007-11-05 | 2010-06-02 | 南京大学 | Bisinomenine derivatives linked by carbon-carbon mode, preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102788843B1 (en) | Steroid derivative FXR agonist | |
| RU2617696C2 (en) | Methods and compounds that can be used to synthesize orexin-2 receptors antagonists | |
| JPWO1993015081A1 (en) | Morphinan derivatives and pharmaceutical uses | |
| JPWO1995003308A1 (en) | Morphinan derivatives and pharmaceutical uses | |
| JP4016986B2 (en) | Treatment or prevention agent for pollakiuria or urinary incontinence and morphinan derivative having nitrogen-containing cyclic substituent | |
| IL255111A (en) | 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors | |
| FR2926555A1 (en) | New azabicyclic carboxamide compounds are transient receptor potential vanilloid type 1 receptor modulators, useful to treat e.g. pain, inflammation, metabolic disorders, depression, gynecological disorders, psoriasis and pruritus | |
| EP0663401A1 (en) | Morphinan derivative and medicinal use | |
| US5972953A (en) | Brain cell protective agent | |
| CN1427840A (en) | Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists | |
| PL193484B1 (en) | Piperidinylaminoethyl trifluoromethyl cyclic ethers as antagonists of substance p | |
| CN108517001A (en) | Water-soluble allopregnenolone derivative and application thereof | |
| CN101538221A (en) | Preparation method of Oseltamivir phosphate | |
| JP5266051B2 (en) | Non-phenolic opioids with large substituents | |
| TW202134248A (en) | Sstr5 antagonists | |
| BRPI0911538A2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A BENZIMIDAZOL DERIVED COMPOUND AND USE OF THE COMPOUND | |
| CN1785976A (en) | N-alkyl diversine and its preparation method | |
| CN1785977A (en) | 17-sulfonyl diversine and its preparation method | |
| JPH1087667A (en) | Morphinan hydroxamic acid compound | |
| AU2009269720A1 (en) | Chromane derivatives as TRPV3 modulators | |
| CN100408578C (en) | A class of 17-acyl sinomenine derivatives and its preparation method | |
| CN1882526A (en) | Process for the preparation of voglibose | |
| JP2008523045A (en) | 1,2,3,3A, 8,8A-hexahydro-2,7A-diada-cyclopenta that binds to a neuronal nicotinic acetylcholine specific receptor site and is useful for the modulation of cholinergic function and the treatment of addictive disorders [A] Inden-7-one derivative | |
| CN110981838A (en) | 5-Imine-tetrahydrofuranylmethylamine derivative and its preparation method and application | |
| EP1959956A2 (en) | Sinomenine derivatives and preparation and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |



